U.S. Bans Imports from BGI and MGI Over Forced Labor Allegations
nashnova research
The Department of Homeland Security has added BGI Group, BGI Genomics, and MGI Tech to the Uyghur Forced Labor Prevention Act entity list, barring all three companies' goods from entering the US — the most damaging restriction yet on the BGI family, signaling Washington is systematically using forced-labor law to block Chinese genomics firms' global reach.
What does this ban actually do?
Three companies — BGI Group, BGI Genomics, and MGI Tech — are now on the UFLPA entity list, a federal law enacted in 2021 that presumes listed firms' goods are made with forced labor.
This means → their products are blocked from the US by default; importers must prove the goods are clean before entry is allowed.
Key context: the list now covers 190 entities, and not a single one has ever successfully cleared the evidentiary bar to regain import access.
In plain terms = once you're on this list, the US market door is effectively shut for good.
Weren't the BGI companies already blacklisted?
Yes — all three were already on other US restriction lists, facing technology-access limits and government-procurement bans.
But those measures controlled what America could *sell to* or *buy from* these firms.
This means → the UFLPA ban is different — it cuts off whether their goods can enter the US market at all, an escalation from restricting the supply side to blocking the demand side.
How big is the financial hit?
BGI Genomics: Americas revenue is under 2% of total sales in 2025 — limited direct impact.
MGI Tech: roughly 8% of revenue comes from the Americas, and the company had already warned that geopolitical pressure was dragging on business.
MGI decided in February to divest its US subsidiary Complete Genomics, citing "an increasingly harsh US policy environment."
In plain terms = the dollar loss is small, but MGI was already retreating from the US — the ban is more an official stamp on an exit already underway.
What is the bigger game?
Last year China placed US sequencing leader Illumina on its unreliable-entity list and banned Illumina's sequencers from the Chinese market — Illumina is MGI Tech's direct competitor.
This reflects a tit-for-tat pattern: "you block my companies, I ban your products" — now entrenched in life sciences.
After the US expanded its forced-labor list in July this year — targeting lower-profile firms — China promptly sanctioned six US entities in response.
This means → whether Beijing retaliates again after the BGI listing is the key signal to watch next.
What does BGI say?
BGI has previously stated that it respects human rights and denied involvement in surveillance of ethnic minorities.
Beijing denies allegations of genocide against Uyghurs and other Muslim minorities in Xinjiang.
None of the three companies responded immediately to the new sanctions.
市场有风险，内容仅供研究参考，不构成投资建议。